Search Results - "ARONOVICH, E. .L"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    The Sleeping Beauty transposon system: a non-viral vector for gene therapy: Gene Therapy by ARONOVICH, Elena L, MCIVOR, R. Scott, HACKETT, Perry B

    Published in Human molecular genetics (15-04-2011)
    “…Over the past decade, the Sleeping Beauty (SB) transposon system has been developed as the leading non-viral vector for gene therapy. This vector combines the…”
    Get full text
    Journal Article
  2. 2

    Molecular genetic defect underlying α-L-iduronidase pseudodeficiency by ARONOVICH, E. .L, DAO PAN, WHITLEY, C. B

    “…Mucopolysaccharidosis type I (i.e., Hurler, Hurler-Scheie, and Scheie syndromes) and type II (i.e., Hunter syndrome) are lysosomal storage disorders resulting…”
    Get full text
    Journal Article
  3. 3

    Genotype-Phenotype Correspondence in Sanfilippo Syndrome Type B by Zhao, Hong G., Aronovich, Elena L., Whitley, Chester B.

    Published in American journal of human genetics (01-01-1998)
    “…Sanfilippo syndrome type B, or mucopolysaccharidosis type IIIB, results from defects in the gene for α-N-acetylglucosaminidase (NAGLU); only a few mutations…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Molecular diagnosis of mucopolysaccharidosis type II (Hunter syndrome) by automated sequencing and computer-assisted interpretation : toward mutation mapping of the iduronate-2-sulfatase gene by JONSSON, J. J, ARONOVICH, E. L, BRAUN, S. E, WHITLEY, C. B

    Published in American journal of human genetics (01-03-1995)
    “…Virtually all mutations causing Hunter syndrome (mucopolysaccharidosis type II) are expected to be new mutations. Therefore, as a means of molecular diagnosis,…”
    Get full text
    Journal Article
  6. 6

    Diagnosis and prevention of lysosomal storage diseases in Russia by Krasnopolskaya, K. D., Mirenburg, T. V., Aronovich, E. L., Lebedeva, T. V., Odinokova, O. N., Demina, N. A., Kozlova, V. M., Kuznetsov, M. I.

    Published in Journal of inherited metabolic disease (01-11-1993)
    “…Summary A special programme for the diagnosis and prevention of lysosomal storage diseases (LSD) was developed in the former USSR. All the patients from 814…”
    Get full text
    Journal Article
  7. 7

    Molecular Basis of Mucopolysaccharidosis Type IIIB in Emu (Dromaius novaehollandiae): An Avian Model of Sanfilippo Syndrome Type B by Aronovich, Elena L., Johnston, Jade M., Wang, Ping, Giger, Urs, Whitley, Chester B.

    Published in Genomics (San Diego, Calif.) (15-06-2001)
    “…Sanfilippo syndrome type B, or mucopolysaccharidosis (MPS) IIIB, is an autosomal recessive disease caused by a deficiency of lysosomal…”
    Get full text
    Journal Article
  8. 8

    Canine Heparan Sulfate Sulfamidase and the Molecular Pathology Underlying Sanfilippo Syndrome Type A in Dachshunds by Aronovich, Elena L., Carmichael, K.Paige, Morizono, Hiroki, Koutlas, Ioannis G., Deanching, Minerva, Hoganson, George, Fischer, Andrea, Whitley, Chester B.

    Published in Genomics (San Diego, Calif.) (15-08-2000)
    “…Heparan sulfate sulfamidase (HSS) is a lysosomal exohydrolase that, when deficient, results in intralysosomal accumulation of heparan sulfate and the clinical…”
    Get full text
    Journal Article
  9. 9

    Preclinical studies of lymphocyte gene therapy for mild Hunter syndrome (mucopolysaccharidosis type II) by Braun, S E, Pan, D, Aronovich, E L, Jonsson, J J, McIvor, R S, Whitley, C B

    Published in Human gene therapy (10-02-1996)
    “…To explore the feasibility of ex vivo lymphocyte gene therapy for mild Hunter syndrome (mucopolysaccharidosis type II), we evaluated retrovirus-mediated gene…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12

    Excision of Sleeping Beauty transposons: parameters and applications to gene therapy by Liu, Geyi, Aronovich, Elena L., Cui, Zongbin, Whitley, Chester B., Hackett, Perry B.

    Published in The journal of gene medicine (01-05-2004)
    “…A major problem in gene therapy is the determination of the rates at which gene transfer has occurred. Our work has focused on applications of the Sleeping…”
    Get full text
    Journal Article
  13. 13

    Prenatal diagnosis of hereditary lysosomal diseases by Mirenburg, T V, Aronovich, E L, Lebedeva, T V, Akhunov, V S, Krasnopol'skaia, K D

    Published in Voprosy meditsinskoi khimii (01-07-1988)
    “…Prenatal diagnosis was carried out in 10 families suffering from lysosomal diseases: Tay-Sachs disease--5 families, Sandhoff disease--1 family,…”
    Get more information
    Journal Article
  14. 14

    Isolation and characteristics of hexosaminidase A and activator protein from human kidney by Aronovich, E L, Akhunov, V S, Krasnopol'skaia, K D

    Published in Biokhimiia (Moscow, Russia) (01-01-1990)
    “…Hexosaminidase A (HA) was isolated from human kidney and purified to an electrophoretically homogeneous state. The purification procedure included ion-exchange…”
    Get more information
    Journal Article
  15. 15

    Study of the genetic heterogeneity of gangliosidoses in humans by Akhunov, V S, Aronovich, E L, Krasnopol'skaia, K D, Mirenburg, T V

    Published in Genetika (01-10-1989)
    “…A study of genetic heterogeneity of GM1 and GM2 gangliosidoses was performed using a wide set of cultured fibroblast lines of patients with leukodystrophies…”
    Get more information
    Journal Article
  16. 16

    Detection of homozygotes and heterozygote carriers of GM2-gangliosidosis by Aronovich, E L, Krasnopol'skaia, K D, Kukharenko, V I, Pichugina, E M

    Published in Genetika (01-08-1986)
    “…11 patients with Tay-Sachs disease (TSD) and 4 patients with Sandhoff disease were identified using the methods of heat inactivation of hexosaminidase at 50…”
    Get more information
    Journal Article
  17. 17

    A program of prevention of hereditary lysosomal diseases in the USSR by Krasnopol'skaia, K D, Mirenburg, T V, Aronovich, E L, Lebedeva, T V, Akhunov, V S, Odinokova, O N, Chebysheva, M V, Demina, N A, Nikiforova, O K, Kuznetsov, M I

    “…The organization of genetic counselling for the families of patients with lysosomal storage diseases (LSD) was based on the interaction of the genetic…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20